These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37037211)

  • 1. Historical Perspectives on the Neurologic Manifestations of Viral Pandemics.
    Holroyd KB; Berkowitz AL
    Semin Neurol; 2023 Apr; 43(2):187-194. PubMed ID: 37037211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic and muscular complications of the 2009 influenza A (H1N1) pandemic.
    Davis LE
    Curr Neurol Neurosci Rep; 2010 Nov; 10(6):476-83. PubMed ID: 20697982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic Complications of COVID-19.
    Gill C; Cho TA
    Continuum (Minneap Minn); 2023 Jun; 29(3):946-965. PubMed ID: 37341337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study.
    Hafsteinsdóttir B; Dalemo E; Elíasdóttir Ó; Ólafsson E; Axelsson M
    Neuroepidemiology; 2023; 57(1):1-6. PubMed ID: 36366822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection.
    Grisanti SG; Franciotta D; Garnero M; Zuppa A; Massa F; Mobilia EM; Pesce G; Schenone A; Benedetti L
    J Neuroimmunol; 2021 Aug; 357():577605. PubMed ID: 34058509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular Complications of COVID-19: Evidence from the Third Year of the Global Pandemic.
    Suh J; Amato A
    Semin Neurol; 2023 Apr; 43(2):251-259. PubMed ID: 37001556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.
    Taga A; Lauria G
    J Peripher Nerv Syst; 2022 Mar; 27(1):4-30. PubMed ID: 35137496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.
    Valderas C; Méndez G; Echeverría A; Suarez N; Julio K; Sandoval F
    World J Pediatr; 2022 Jun; 18(6):373-382. PubMed ID: 35476245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term neurologic outcomes of COVID-19.
    Xu E; Xie Y; Al-Aly Z
    Nat Med; 2022 Nov; 28(11):2406-2415. PubMed ID: 36138154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological Involvements of SARS-CoV2 Infection.
    Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
    Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain Barre Syndrome associated with COVID-19 Infection: A Case Report.
    Shrestha S; Kc N; Hirachan N
    JNMA J Nepal Med Assoc; 2021 Aug; 59(240):808-811. PubMed ID: 34508476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: A Global Threat to the Nervous System.
    Koralnik IJ; Tyler KL
    Ann Neurol; 2020 Jul; 88(1):1-11. PubMed ID: 32506549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic complications of COVID-19.
    Bridwell R; Long B; Gottlieb M
    Am J Emerg Med; 2020 Jul; 38(7):1549.e3-1549.e7. PubMed ID: 32425321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.
    Munhoz RP; Pedroso JL; Nascimento FA; Almeida SM; Barsottini OGP; Cardoso FEC; Teive HAG
    Arq Neuropsiquiatr; 2020 May; 78(5):290-300. PubMed ID: 32490966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.